nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance
|
Nijstad, A. Laura |
|
|
164 |
C |
p. 137-154 |
artikel |
2 |
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy
|
Pece, Salvatore |
|
|
164 |
C |
p. 52-61 |
artikel |
3 |
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
|
Kroese, Tiuri E. |
|
|
164 |
C |
p. 18-29 |
artikel |
4 |
Does sex matter? Analysis of sex-related differences in the diagnostic performance of a market-approved convolutional neural network for skin cancer detection
|
Sies, Katharina |
|
|
164 |
C |
p. 88-94 |
artikel |
5 |
Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study
|
Lin, Ningjing |
|
|
164 |
C |
p. 117-126 |
artikel |
6 |
Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours
|
Maniar, Ashray |
|
|
164 |
C |
p. 95-104 |
artikel |
7 |
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study
|
Dalenc, Florence |
|
|
164 |
C |
p. 70-79 |
artikel |
8 |
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies
|
Edeline, Julien |
|
|
164 |
C |
p. 80-87 |
artikel |
9 |
Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities
|
Nahm, Sharon H. |
|
|
164 |
C |
p. 62-69 |
artikel |
10 |
PD-1 inhibitors in patients with Hodgkin lymphoma
|
Rossi, Cédric |
|
|
164 |
C |
p. 114-116 |
artikel |
11 |
Precision dosing in children; no small matter
|
Hanff, L.M. |
|
|
164 |
C |
p. 155-156 |
artikel |
12 |
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial
|
Hagel, Christian |
|
|
164 |
C |
p. 30-38 |
artikel |
13 |
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant
|
Malorni, Luca |
|
|
164 |
C |
p. 39-51 |
artikel |
14 |
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients
|
Alifrangis, Constantine |
|
|
164 |
C |
p. 105-113 |
artikel |
15 |
Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma
|
Brivio, Erica |
|
|
164 |
C |
p. 1-17 |
artikel |
16 |
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
|
Barnett, Shelby |
|
|
164 |
C |
p. 127-136 |
artikel |